Grant ID RP150032
Awarded On February 18, 2015
Title Developing New Combinatory Therapies for Pediatric High Grade Glioma
Program Academic Research
Award Mechanism Individual Investigator Research Awards for Cancer in Children and Adolescents
Institution/Organization Baylor College of Medicine
Principal Investigator/Program Director Xiao-Nan Li
Cancer Sites Brain and Other Nervous System
Contracted Amount $1,945,940
Lay Summary

The five year survival in children with high grade glioma is still less than 10%. Recent advances of genomic sequencing methods have made it possible to discover nearly all gene mutations in pediatric gliomas. The objective of this application is therefore to develop new combinatory therapies that will selectively target those mutations critical for tumor cell survival. Since most of the tumors have many different mutated genes, we have designed a new “anchor-probe” strategy to selectively and efficiently target multiple abnormalities. Based on the genetic concept known as “synthetic lethality”, we hypothesize that simultaneous perturbation of two (or more) mutated genes can result in a dead...

Read More